Study guide
Ectasia imaging, cross-linking and rehabilitation
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Ectasia imaging, cross-linking and rehabilitation
Key Takeaways Explain This Topic AI
Tomography assesses posterior shape and thickness in addition to anterior topography.
Cross-linking aims to limit progression; its safety and biological response depend on the actual protocol and cornea.
Optical correction, ring segments and graft surgery address different functional and anatomical problems.
Last updated: October 2026
3. Diagnostic Corneal Imaging: Topography vs Tomography
Early diagnosis of keratoconus is essential because corneal collagen cross-linking aims to arrest progression before irreversible visual loss occurs.
Placido Disc Topography
Reflects concentric mire rings off the anterior tear film to map anterior corneal curvature:
Axial (Sagittal) Curvature Maps : Displays classic asymmetric bowtie patterns with skewed radial axes (SRAX > 22 ∘ > 22^\circ > 2 2 ∘ ).
Inferior Steepening (I-S Value) : Compares average keratometric power 3 mm inferior to the centre with 3 mm superior. An I − S difference > 1.4 – 1.9 D I-S\text{ difference} > 1.4–1.9\text{ D} I − S difference > 1.4–1.9 D is diagnostic of early keratoconus.
Central Keratometry : K max > 47.2 – 48.0 D K_{\text{max}} > 47.2–48.0\text{ D} K max > 47.2–48.0 D is highly suspicious.
Scheimpflug Tomography (Pentacam / Galilei / Sirius)
Scheimpflug imaging utilizes a rotating camera to capture optical sections from the anterior corneal surface through the posterior lens capsule, generating true 3D elevation maps and pachymetric profiles:
Posterior elevation may reveal ectatic change missed by anterior-only topography; interpretation depends on the reference surface, scan quality and device.
Pachymetric progression measures how thickness changes from the thinnest region outward.
ART and BAD-D combine multiple measurements. Device warning colours and thresholds are screening aids, not standalone confirmation.
Compare repeatable maps, clinical thinning, refraction and family/atopic history. Dry eye and contact-lens warpage can produce misleading maps; obtain stable measurements before planning treatment.
- 4. Pellucid Marginal Degeneration & Keratoglobus
- Pellucid Marginal Degeneration (PMD)
PMD is a bilateral, non-inflammatory ectatic disorder characterised by a peripheral band of stromal thinning located 1 to 2 mm from the inferior limbus , typically spanning between the 4 o'clock and 8 o'clock positions.
Biomicroscopic Hallmark : The cornea protrudes immediately superior to the band of thinning. Crucially, the thinnest area is completely clear, avascular, and lacks lipid deposition (differentiating it from Terrien marginal degeneration, which displays superficial vascularisation and lipid arcs).
Topography : A suggestive "crab-claw" , "butterfly" , or "kissing-birds" pattern on sagittal curvature maps.
Refraction : Marked against-the-rule astigmatism , with a relatively steep horizontal meridian.
Keratoglobus
A rare bilateral non-inflammatory disorder characterised by generalised, uniform thinning of the entire cornea from limbus to limbus , with maximum thinning in the periphery.
The cornea assumes a smooth, globular, spherical protrusion. Because the entire corneal periphery is paper-thin ( < 200 – 300 μ m < 200–300\,\mu\text{m} < 200–300 μ m ), patients are at catastrophic risk of globe rupture following trivial blunt trauma .
Strongly associated with blue sclera, hypermobility, and Ehlers-Danlos syndrome type VI.
5. Corneal Collagen Cross-Linking (CXL)
Corneal collagen cross-linking is the only proven medical intervention capable of arresting the progression of corneal ectatic disorders.
Photochemical Mechanism
Riboflavin and ultraviolet-A exposure generate photochemical reactions that increase stromal cross-linking. Oxygen availability and protocol affect the response. Laboratory stiffness increases do not supply a universal percentage of clinical strengthening or a guarantee that progression will stop in every treated cornea.
Indications & Documented Progression Criteria
Progression is a consistent change beyond measurement noise in at least two of anterior steepening, posterior steepening and progressive thinning or altered thickness distribution. A repeatable change in refraction and acuity supports the assessment. Numerical trial criteria are not universal diagnostic laws. In children, rapid progression risk may justify early cross-linking without waiting a compulsory twelve months.
The Standard Dresden Protocol
Epithelial Debridement (Epi-Off) : The central 8.0 to 9.0 mm of corneal epithelium is mechanically removed under topical anaesthesia. The intact hydrophobic epithelium possesses tight junctions ( zonula occludens ) that prevent riboflavin penetration and absorbs UV-A light.
Riboflavin Saturation : Iso-osmolar 0.1% riboflavin in 20% dextran T500 is instilled every 2 minutes for 30 minutes. Adequate penetration is verified on slit lamp by observing yellow riboflavin flare within the anterior chamber.
Safety Pachymetry Threshold : Minimum deepithelialised stromal thickness must be ≥ 400 μ m \ge 400\,\mu\text{m} ≥ 400 μ m . The cytotoxic threshold of UV-A radiation for corneal endothelial cells is 0.37 mW/cm 2 0.37\text{ mW/cm}^2 0.37 mW/cm 2 . A 400 μ m 400\,\mu\text{m} 400 μ m riboflavin-saturated stroma absorbs > 95 % > 95\% > 95% of incident UV-A, keeping endothelial irradiance below 0.18 mW/cm 2 0.18\text{ mW/cm}^2 0.18 mW/cm 2 .
Thin corneas require a specialist validated modified protocol, reassessment during treatment, or deferral. Transient swelling to 400 micrometres does not by itself establish that standard irradiation is safe.
UV-A Irradiation : 365 nm 365\text{ nm} 365 nm UV-A light delivered at an irradiance of 3 mW/cm 2 3\text{ mW/cm}^2 3 mW/cm 2 for 30 minutes , delivering a total cumulative surface fluence of 5.4 J/cm 2 5.4\text{ J/cm}^2 5.4 J/cm 2 ( 3 mW/cm 2 × 1800 s = 5400 mJ/cm 2 = 5.4 J/cm 2 3\text{ mW/cm}^2 \times 1800\text{ s} = 5400\text{ mJ/cm}^2 = 5.4\text{ J/cm}^2 3 mW/cm 2 × 1800 s = 5400 mJ/cm 2 = 5.4 J/cm 2 ).
Demarcation Line : Anterior segment optical coherence tomography (AS-OCT) at 1 month reveals a distinct hyper-reflective line at approximately 300 μ m 300\,\mu\text{m} 300 μ m depth , marking the transition between cross-linked and untreated posterior stroma.
Accelerated & Transepithelial (Epi-On) CXL
Accelerated CXL : 9 mW/cm² for 600 seconds, 18 for 300 seconds and 30 for 180 seconds each deliver 5.4 J/cm². Equal fluence does not guarantee an equal biological effect: oxygen replenishment, riboflavin and pulsing influence cross-linking. Compare clinical evidence for the specific protocol.
Transepithelial (Epi-On) CXL : Employs chemical penetration enhancers (benzalkonium chloride, EDTA, or iontophoresis) to deliver riboflavin across intact epithelium. Avoids postoperative pain and infection risk, but clinical stabilization rates have historically been slightly lower than epi-off.
6. Optical & Surgical Visual Rehabilitation
Rigid Gas Permeable (RGP) Lenses : The gold standard for visual rehabilitation in moderate keratoconus. The tear lens trapped between the rigid rear surface of the lens and the irregular anterior corneal surface neutralizes anterior irregular astigmatism.
Scleral Contact Lenses : Large-diameter gas-permeable lenses that vault entirely over the ectatic cornea and limbus , resting exclusively on the relatively insensitive bulbar conjunctiva and sclera. Fluid-filled reservoir provides superb comfort, ocular surface hydration, and optical neutralization for advanced keratoconus.
Intrastromal Corneal Ring Segments (ICRS / Keraring / Ferrara / Intacs) : Arcuate polymethylmethacrylate (PMMA) segments implanted into channels dissected in the deep stroma (at 70% to 80% depth) using a femtosecond laser. By Barraquer's thickness law, adding volume in the corneal periphery flattens the central cornea, reduces refractive myopia and astigmatism, and improves contact lens tolerance in patients with clear central corneas.